[Home] [Databases] [World Law] [Multidatabase Search] [Help] [Feedback] | ||
England and Wales High Court (King's Bench Division) Decisions |
||
You are here: BAILII >> Databases >> England and Wales High Court (King's Bench Division) Decisions >> Bailey & Ors v GlaxoSmithKline UK Ltd [2025] EWHC 186 (KB) (31 January 2025) URL: http://www.bailii.org/ew/cases/EWHC/KB/2025/186.html Cite as: [2025] EWHC 186 (KB) |
[New search] [Printable PDF version] [Help]
KING'S BENCH DIVISION
Strand, London, WC2A 2LL |
||
B e f o r e :
____________________
SANDRA BAILEY AND OTHERS |
Claimants |
|
- and - |
||
GLAXOSMITHKLINE UK LIMITED |
Defendant |
|
- and - |
||
BRIT UW LIMITED (the corporate capital provider of Lloyd's Syndicate 2987 for the 2015 year of account) |
Respondent |
____________________
Jason Robinson (instructed by CMS) for the Respondent
Hearing date: 15 January 2025
____________________
Crown Copyright ©
The Hon. Mr Justice Bourne:
Introduction
"Subject to the provisions of this or any other Act and to rules of court, the costs of and incidental to all proceedings in the civil division of the Court of Appeal and in the High Court, including the administration of estates and trusts, shall be in the discretion of the court, and the court shall have full power to determine by whom and to what extent the costs are to be paid";
a. By a Claim Form served on 30 April 2004, several hundred publicly funded Claimants claimed that the Defendant's anti-depressant medication Seroxat was defective and had caused them harm.
b. A Group Litigation Order was made on 9 July 2007.
c. A number of generic issues were listed for a trial commencing on 1 February 2011.
d. However, on 29 November 2010, the Legal Services Commission decided to discharge the Claimants' public funding certificate after considering an advice on the merits from their then leading counsel.
e. That led to 369 Claimants discontinuing their claims, while the remaining 124 challenged the LSC's decision.
f. On 29 January 2015 a review panel rejected that challenge and discharged the public funding certificate.
g. On 22 July 2015, a notice of change of legal representative was served by Fortitude Law, referring to its acceptance of instructions following "discussions with funders and insurers". It represented 102 Claimants, whilst one more continued as a litigant in person. An adjourned CMC was listed for hearing on 28 October 2015.
h. Solicitors' correspondence between August and October 2015 addressed, among other things, the adequacy of the proposed funding arrangements including any "after the event" ("ATE") insurance cover for costs liabilities.
i. In letters dated 14 August and 16 October 2015, Fortitude Law stated that ATE insurance had been obtained for the remaining Claimants in respect of adverse costs orders relating to the generic case and represented that there was an adequate initial level of indemnity, with a facility to obtain further cover if required.
j. The Defendant's solicitors questioned those assertions. At the CMC on 28 October 2015, Foskett J required the Claimants to provide further information including a detailed explanation of the contention that there was adequate cover.
k. On 19 November 2015, Brit issued an ATE legal expenses policy to the Claimants.
l. On 26 November 2015, in a witness statement by Mr Hanison in response to Foskett J's order, it was stated that (1) litigation funding had been provided by Managed Legal Solutions Ltd ("MLS") which exceeded the remaining £500,000 which had previously been available under the public funding certificate and (2) the ATE insurance with Brit would, if necessary, reimburse the Defendant's reasonable costs up to £750,000.
m. On 4 February 2016, Foskett J gave a judgment following the adjourned CMC in which he allowed the proceedings to continue, noting that the ATE insurance meant "that there is the prospect of recovery of at least some of its reasonable recoverable costs by the Defendant if the claims fail or are discontinued".
n. On 16 June 2017 the Defendant applied for security for costs. On 3 August 2017 MLS's head of investment in a witness statement expressed the view that the ATE policy provided the Defendant with sufficient comfort in respect of the first £750,000 of its costs.
o. On 8 December 2017, Foskett J ordered the Claimants to provide security for costs in the sum of £1.75 million, that sum being half of the Defendant's anticipated recoverable costs up to the start of a trial, less two thirds of the ATE cover, the remaining third being disregarded to reflect the "more than minimal risk" that the insurance policy might be avoided.
p. The trial commenced on 29 April 2019 before Lambert J. An issue as to the Claimants' case on defect arose during opening and was decided in the Defendant's favour on day 3 of the trial, for reasons given in a judgment on 9 May 2019. Permission to appeal was refused by the Court of Appeal on 4 December 2019 and by the Supreme Court on 24 January 2020.
q. On 7 May 2020, the Claimants by their counsel submitted to judgment dismissing the claims, subject only to arguments as to costs.
r. On 3 July 2020 Lambert J ordered that judgment be entered. She also ordered the Claimants to pay costs to the Defendant on the indemnity basis up to 21 June 2018 and on the standard basis thereafter. Each claimant was liable for his/her individual costs and his/her share of the common costs. The judge ordered a payment on account of £4.5 million but the question of time for that payment was adjourned generally with liberty to restore.
s. Paragraph 5 of that order contained the deadline which the Defendant now seeks to extend:
"The Defendant shall make any application for a third party costs order (including but not limited to any application for the payment out, to the Defendant, of monies currently standing in Court as security for the Defendant's costs), if so advised, no later than 4pm on 31 July 2020. Any such application shall include the Defendant's proposed directions and timetable, and shall be placed before Lambert J for directions for the filing of any evidence by the parties to that application and for the hearing of that application. Such application may include an application to restore the question of when the payment ordered in paragraph 4 should be made. For the avoidance of all doubt, any such application should be served on the Claimants' solicitors."
t. In September 2020 MLS and its owner, a Mr Hunt, agreed to pay £5 million, including the money paid into court as security for costs, to the Defendant in settlement of their liability for costs.
a. In addition to the monies recovered from MLS and its owner, the Defendant had incurred an estimated £4,381,029 in costs between 1 October 2015 and 3 July 2020.
b. On 29 July 2020 its solicitors wrote to Fortitude Law asking whether the Claimants had made a claim under the policy and, if so, the status of the claim.
c. On 13 November 2020 Fortitude Law confirmed that the Claimants had made a claim, and on 9 December 2020 they indicated that an update was being chased via the insurance broker.
d. On 5 January 2021 the Defendant's solicitors sent a chasing email to Fortitude Law but received no response.
e. On 6 August 2021 and again on 2 September 2021 the Defendant's solicitors wrote directly to Brit, asking it to confirm the Claimants' insurance cover and the status of their claim under the policy.
f. On 7 September 2021, CMS Cameron McKenna Nabarro Olswang LLP ("CMS") acknowledged receipt of those letters and stated that CMS was advising Brit in relation to the Seroxat Group Litigation. In a telephone call on that date, CMS would not confirm the position that Brit was taking in relation to the Claimants' insurance claim, or the status of that claim, but said that CMS were investigating the case and advising Brit and had been trying without success to contact Fortitude Law, and asked the Defendant to co-operate by sharing any relevant information.
g. The Defendant's solicitors sent chasing letters or emails to CMS on 26 October 2021 (providing documents containing information requested by Brit), 12 January 2022, 20 April 2023 and 16 May 2023.
h. A substantive response was received on 25 May 2023, stating that Brit to the best of its knowledge had not received any claim from the insured Claimants and "has not confirmed insurance cover under the ATE policy in the absence of any claim by the insured Claimants".
a. Is this a case where relief from sanction must be sought under CPR 3.9, or is it just a request for an extension which will be decided by applying the overriding objective under CPR 1.1?
b. Whichever of those tests is applied, should the Defendant be granted relief from sanction or the desired extension as the case may be, or not?
"1.1
(1) These Rules are a procedural code with the overriding objective of enabling the court to deal with cases justly and at proportionate cost.
(2) Dealing with a case justly and at proportionate cost includes, so far as is practicable –
(a) ensuring that the parties are on an equal footing and can participate fully in proceedings, and that parties and witnesses can give their best evidence;
(b) saving expense;
(c) dealing with the case in ways which are proportionate –
(i) to the amount of money involved;
(ii) to the importance of the case;
(iii) to the complexity of the issues; and
(iv) to the financial position of each party;
(d) ensuring that it is dealt with expeditiously and fairly;
(e) allotting to it an appropriate share of the court's resources, while taking into account the need to allot resources to other cases;
f) promoting or using alternative dispute resolution; and
(g) enforcing compliance with rules, practice directions and orders.
3.9
(1) On an application for relief from any sanction imposed for a failure to comply with any rule, practice direction or court order, the court will consider all the circumstances of the case, so as to enable it to deal justly with the application, including the need –
(a) for litigation to be conducted efficiently and at proportionate cost; and
(b) to enforce compliance with rules, practice directions and orders.
(2) An application for relief must be supported by evidence."
The parties' submissions
"I need mention three preliminary points. First, the Qualified One Way Costs regime does not apply to this claim as it started well before that regime came into effect in 2013. Second, the costs in issue relate principally to the costs incurred by the Defendant following the resurrection of the action in 2015. Although there is an outstanding costs liability dating back to the period when the Claimants had the benefit of public funding, the Defendant accepts that it will be unlikely to be able to enforce that liability. The Defendant's Schedule of Costs for the purpose of an interim payment therefore relates only to costs incurred since 31 July 2015. That said, the costs figure is very high, running to just under £9.33 million. Third, the Defendant seeks an order for costs against the Claimants not to be enforced without the further order of the Court. I am informed that a further application may be made against the third party litigation funders MLS who have already been required to provide a security for the Defendant's costs under CPR 25.14(1) by making a payment into court in the sum of £1,750,000 pursuant to the Order of Foskett J of 11 December 2017. This sum was increased by £750,000 by a consent order dated 11 October 2018."
(emphasis added)
"… the question whether a defendant should be permitted to make an application under CPR 17.2(2) after the period specified in it has expired must be determined by reference to the overriding objective. It may still be relevant to consider the matters reflected in the Denton three-stage test (seriousness and significance of the delay, the reasons for it and other relevant circumstances), but, unlike an application for relief from sanction, the matter should not be approached on the basis that the 'starting point' is that 'the sanction has been properly imposed and complies with the overriding objective' …".[1]
Discussion
"Bearing in mind the importance of clarity in the procedural framework to be followed by court users, the hurdle for identifying something as an unexpressed but implicit sanction must be a high one. It has been identified in the two circumstances mentioned in the cases above. I prefer to say that the scope for identifying any further implied sanctions over and above these two must be very narrow. Bearing in mind that the Denton 'ethos' may apply even when r3.9 is not engaged, the need for further extensions of this concept is likely to be very limited."
" … there are really three categories of case: (i) cases where the rule or order expressly provides for the sanction that will apply on non-compliance (eg failure to file witness statements on time, (ii) cases where the rule does not expressly state the sanction which applies for non-compliance, but permission of the court is needed to proceed (eg failure to file a notice of appeal on time), and (iii) cases where a further step is taken in consequence of the non-compliance, such as the entry of a default judgment (as in this case) or the striking out of a claim for non-attendance at trial …".
a. There is no issue in this case about equality of arms or access to court.
b. Saving expense is not directly relevant, as the TPCO application would have occasioned expense whenever it was made.
c. As to proportionality, I bear in mind in the Defendant's favour that a significant sum of £750,000 is involved, though that should be seen in the context of the recovery of a much larger sum in costs from MLS. Neither party has prayed in aid anything specific about its own financial position.
d. Logically, the need to deal with cases fairly will tend to favour permitting a party to have an issue decided. This is not a case where allowing an extension would cause significant prejudice to Brit, over and above the prejudice of having to deal with litigation which at one stage appeared to have fallen dormant. But the need to deal with cases expeditiously carries greater weight in the present circumstances. I have explained why the Defendant has at all times failed to act in a way which merits the Court's indulgence in granting a long extension of time.
e. Allotting an appropriate share of the Court's resources is not a decisive factor in this case, because the proposed application would have consumed resources whenever it was made.
f. The other factor of critical importance in the present case is the need to enforce compliance with the Court's orders. The Defendant does not appear to have considered the workability of the deadline when the order of 3 July 2020 was made. At no time thereafter did the Defendant appear to appreciate that it would need a substantial extension of the time within which Lambert J had sought to have the residual issues in this litigation dealt with, and it never showed any sense of urgency in pursuing the question, even after it had told Brit that it would be making its applications.
Conclusion
Note 1 The quotation is from Mitchell v News Group Newspapers Ltd (Practice Note) [2013] EWCA Civ 1537, [2014] 1 WLR 795 per Lord Dyson MR at [45]. [Back]